Evidence map›Paper›PMID 40009253›Full record

ArticleGastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association2025

Robotic and laparoscopic gastrectomy for gastric cancer: comparative insights into perioperative performance and three-year survival outcomes.

Yuki Ushimaru, Takeshi Omori, Kazuyoshi Yamamoto, Yoshitomo Yanagimoto, Yasunori Masuike, Norihiro Matsuura, Takahito Sugase, Takashi Kanemura, Ryota Mori, Masatoshi Kitakaze and 10 more

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Exercise-nutrition prehabilitation attenuates lean body mass loss before gastrectomy: a randomized controlled trial.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2026
    Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. [Robotic gastrectomy: Research progress and practical challenges].Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences · 2026
    Review
  8. Article
  9. Article
  10. Article
  11. Minimally invasive versus open completion total gastrectomy for remnant gastric cancer: a nationwide propensity score-matched analysis.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2025
    Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Yuki UshimaruDepartment of Gastroenterological Surgery, Osaka International Cancer Institute, 3-1-69 Otemae Chuoku, Osaka City, Osaka, Japan. yuki.ushimaru@oici.jp.ORCID 0000-0003-1096-0980
Takeshi OmoriDepartment of Gastroenterological Surgery, Osaka International Cancer Institute, 3-1-69 Otemae Chuoku, Osaka City, Osaka, Japan.
Kazuyoshi YamamotoDepartment of Gastroenterological Surgery, Osaka International Cancer Institute, 3-1-69 Otemae Chuoku, Osaka City, Osaka, Japan.
Yoshitomo YanagimotoDepartment of Gastroenterological Surgery, Osaka International Cancer Institute, 3-1-69 Otemae Chuoku, Osaka City, Osaka, Japan.
Yasunori MasuikeDepartment of Gastroenterological Surgery, Osaka International Cancer Institute, 3-1-69 Otemae Chuoku, Osaka City, Osaka, Japan.
Norihiro MatsuuraDepartment of Gastroenterological Surgery, Osaka International Cancer Institute, 3-1-69 Otemae Chuoku, Osaka City, Osaka, Japan.
Takahito SugaseDepartment of Gastroenterological Surgery, Osaka International Cancer Institute, 3-1-69 Otemae Chuoku, Osaka City, Osaka, Japan.
Takashi KanemuraDepartment of Gastroenterological Surgery, Osaka International Cancer Institute, 3-1-69 Otemae Chuoku, Osaka City, Osaka, Japan.
Ryota MoriDepartment of Gastroenterological Surgery, Osaka International Cancer Institute, 3-1-69 Otemae Chuoku, Osaka City, Osaka, Japan.
Masatoshi KitakazeDepartment of Gastroenterological Surgery, Osaka International Cancer Institute, 3-1-69 Otemae Chuoku, Osaka City, Osaka, Japan.
Masataka AmisakiDepartment of Gastroenterological Surgery, Osaka International Cancer Institute, 3-1-69 Otemae Chuoku, Osaka City, Osaka, Japan.
Masahiko KuboDepartment of Gastroenterological Surgery, Osaka International Cancer Institute, 3-1-69 Otemae Chuoku, Osaka City, Osaka, Japan.
Yousuke MukaiDepartment of Gastroenterological Surgery, Osaka International Cancer Institute, 3-1-69 Otemae Chuoku, Osaka City, Osaka, Japan.
Hisateru KomatsuDepartment of Gastroenterological Surgery, Osaka International Cancer Institute, 3-1-69 Otemae Chuoku, Osaka City, Osaka, Japan.
Toshinori SuedaDepartment of Gastroenterological Surgery, Osaka International Cancer Institute, 3-1-69 Otemae Chuoku, Osaka City, Osaka, Japan.
Yoshinori KagawaDepartment of Gastroenterological Surgery, Osaka International Cancer Institute, 3-1-69 Otemae Chuoku, Osaka City, Osaka, Japan.
Hiroshi WadaDepartment of Gastroenterological Surgery, Osaka International Cancer Institute, 3-1-69 Otemae Chuoku, Osaka City, Osaka, Japan.
Kunihito GotohDepartment of Gastroenterological Surgery, Osaka International Cancer Institute, 3-1-69 Otemae Chuoku, Osaka City, Osaka, Japan.
Masayoshi YasuiDepartment of Gastroenterological Surgery, Osaka International Cancer Institute, 3-1-69 Otemae Chuoku, Osaka City, Osaka, Japan.
Hiroshi MiyataDepartment of Gastroenterological Surgery, Osaka International Cancer Institute, 3-1-69 Otemae Chuoku, Osaka City, Osaka, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe primary treatment for gastric cancer (GC) is surgical resection, particularly for locally advanced cases. While laparoscopic gastrectomy (LG) has shown short- and long-term benefits, robotic gastrectomy (RG) offers enhanced precision and may lead to better outcomes, especially in advanced-stage disease.

methodsThis retrospective study analyzed data from 1538 patients with pathological Stage I-III GC who underwent RG or LG between 2014 and 2021. Propensity score matching created 466 matched pairs. Perioperative outcomes, 3 year overall survival (OS), 3 year recurrence-free survival (RFS), and recurrence patterns were compared between RG and LG.

resultsRG demonstrated significantly shorter operative time (235.5 vs. 242.5 min, p = 0.001), less blood loss (19.1 vs. 33.4 ml, p < 0.001), and shorter hospital stay (7.9 vs. 9.7 days, p < 0.001). Overall complications did not differ significantly (p = 0.183), but RG had lower rates of anastomotic leakage (p = 0.045) and pancreatic fistula (p = 0.024). No significant differences in OS were observed in the overall cohort or by stage. Similarly, RFS showed no significant differences in the overall cohort (3 year RFS: RG 86.81% vs. LG 83.04%, p = 0.1347). By stage, no differences were found in stage I or II, but in stage III, RG showed better 3 year RFS (67.52% vs. 52.97%, p = 0.0424). RG also had lower recurrence rates (9.0% vs. 14.8%, p = 0.0061), with fewer liver (p = 0.0069) and lymph node metastases (p = 0.0223).

conclusionRG demonstrated superior short-term outcomes and comparable three-year OS to laparoscopic gastrectomy, with improved three-year RFS and reduced recurrence in Stage III, likely facilitated by earlier adjuvant chemotherapy initiation.

Indexed as

GastrectomyLaparoscopyRobotic Surgical ProceduresStomach NeoplasmsAdultAgedFemaleFollow-Up StudiesHumansMaleMiddle AgedNeoplasm Recurrence, LocalOperative TimePostoperative ComplicationsRetrospective StudiesSurvival RateGastrectomyGastric cancerLaparoscopyRobotic Surgical ProcedureSurvival Rate

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.